LAURA SELMAN: Open Payments
NPI 1437780608 · MANDEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$811 in 47 payments from 17 companies in 2025. Trend: 2023 $1,256 · 2024 $1,094 · 2025 $811
Food & beverage: $811
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $195 |
| Amgen Inc. | 6 | $106 |
| GENZYME CORPORATION | 3 | $85 |
| UCB, Inc. | 2 | $63 |
| Arcutis Biotherapeutics, Inc. | 2 | $45 |
| Janssen Biotech, Inc. | 2 | $41 |
| LEO Pharma Inc. | 2 | $37 |
| Organon LLC | 2 | $32 |
| Journey Medical Corporation | 2 | $32 |
| Incyte Corporation | 1 | $30 |
Products named: RINVOQ, OTEZLA, DUPIXENT, SKYRIZI, Bimzelx, Zoryve, TREMFYA, ANZUPGO.
Industry payments across LA — which companies pay providers there.
